X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3071) 3071
Publication (257) 257
Book / eBook (211) 211
Book Review (33) 33
Conference Proceeding (4) 4
Magazine Article (4) 4
Book Chapter (3) 3
Dissertation (3) 3
Government Document (2) 2
Web Resource (2) 2
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2546) 2546
male (1612) 1612
female (1524) 1524
index medicus (1382) 1382
middle aged (1119) 1119
oncology (1049) 1049
aged (994) 994
animals (941) 941
cancer (909) 909
adult (872) 872
gastrointestinal diseases - chemically induced (721) 721
chemotherapy (477) 477
antineoplastic agents - adverse effects (454) 454
mice (414) 414
gastrointestinal diseases (406) 406
neoplasms - drug therapy (367) 367
rats (354) 354
treatment outcome (339) 339
antineoplastic combined chemotherapy protocols - adverse effects (329) 329
tumors (326) 326
colorectal cancer (322) 322
antineoplastic combined chemotherapy protocols - therapeutic use (316) 316
risk factors (311) 311
care and treatment (291) 291
gastrointestinal neoplasms - chemically induced (291) 291
antineoplastic agents - therapeutic use (286) 286
aged, 80 and over (285) 285
gastroenterology & hepatology (285) 285
gastrointestinal neoplasms - drug therapy (267) 267
medicine & public health (267) 267
analysis (260) 260
research article (240) 240
medicine (238) 238
pharmacology & pharmacy (237) 237
research (234) 234
gastrointestinal hemorrhage - chemically induced (230) 230
health aspects (226) 226
therapy (210) 210
hematologic diseases - chemically induced (207) 207
gastrointestinal system (206) 206
dose-response relationship, drug (197) 197
carcinogens (194) 194
science (192) 192
colon cancer (190) 190
multidisciplinary sciences (190) 190
drug administration schedule (189) 189
risk (188) 188
nausea - chemically induced (187) 187
prevention (185) 185
vomiting - chemically induced (185) 185
colorectal-cancer (181) 181
carcinogenesis (178) 178
time factors (178) 178
diseases (177) 177
rodents (177) 177
apoptosis (175) 175
gastroenterology and hepatology (172) 172
surgery (163) 163
adolescent (161) 161
gastrointestinal tumors (161) 161
retrospective studies (160) 160
inflammation (157) 157
gastroenterology (156) 156
fluorouracil - administration & dosage (153) 153
colon (151) 151
digestive system (151) 151
gene expression (151) 151
cancers and neoplasms (150) 150
expression (150) 150
drug therapy (147) 147
fluorouracil - adverse effects (147) 147
gastrointestinal tract (146) 146
prospective studies (145) 145
proteins (143) 143
adenocarcinoma - drug therapy (142) 142
administration, oral (139) 139
biology (138) 138
colonic neoplasms - chemically induced (133) 133
article (132) 132
breast neoplasms - drug therapy (131) 131
disease models, animal (131) 131
gastrointestinal agents (131) 131
toxicity (131) 131
metastasis (126) 126
follow-up studies (124) 124
lung neoplasms - drug therapy (124) 124
child (123) 123
nausea (122) 122
abridged index medicus (121) 121
liver (121) 121
medical research (121) 121
cell line, tumor (120) 120
trial (120) 120
combined modality therapy (118) 118
hematology (118) 118
studies (117) 117
toxicology (116) 116
neoplasms, experimental - chemically induced (115) 115
prognosis (115) 115
carcinoma (114) 114
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (187) 187
Scarborough Hospital - General (7) 7
St. Michael's Hospital - Stacks (6) 6
Lakeridge Health Sciences - Oshawa (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Online Resources - Online (3) 3
Providence Healthcare - Stacks (3) 3
Toronto East General Hospital - Stacks (3) 3
Baycrest Hospital - Stacks (2) 2
Credit Valley Hospital - Reference (2) 2
Gerstein Science - Reference (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Providence Healthcare - Reference (2) 2
Scarborough Hospital - Birchmount (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Toronto East General Hospital - Online (2) 2
Trillium Health Centre - Stacks (2) 2
Church Stacks (1) 1
Credit Valley Hospital - Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Humber River Regional Hospital - Pharmacy (1) 1
Mt Sinai Hospital - Pathology (1) 1
Mt Sinai Hospital - Stacks (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3091) 3091
German (58) 58
Japanese (51) 51
French (43) 43
Spanish (25) 25
Chinese (16) 16
Italian (13) 13
Russian (11) 11
Dutch (5) 5
Polish (5) 5
Romanian (3) 3
Swedish (3) 3
Danish (2) 2
Finnish (2) 2
Hungarian (2) 2
Korean (2) 2
Norwegian (2) 2
Portuguese (2) 2
Turkish (2) 2
Arabic (1) 1
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 76, pp. 144 - 151
Abstract Purpose In tumours with wild-type TP53 , the tumour-suppressive function of p53 is frequently inhibited by HDM2. This phase I, dose-escalating study... 
Hematology, Oncology and Palliative Medicine | HDM2 | De-differentiated liposarcoma | Pharmacodynamics | Solid tumours | MDM2 | Pharmacokinetics | SAR405838 | p53 | LIPOSARCOMA | P53 PATHWAY | TRIAL | AMPLIFICATION | DATABASE | ONCOLOGY | MDM2 ANTAGONIST | MUTATION | INHIBITOR | Lung Neoplasms - drug therapy | Skin Neoplasms - drug therapy | Nausea - chemically induced | Gastrointestinal Neoplasms - drug therapy | Humans | Middle Aged | Spiro Compounds - administration & dosage | Lung Neoplasms - pathology | Male | Fatigue - chemically induced | Antineoplastic Agents - administration & dosage | Spiro Compounds - adverse effects | Indoles - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Gastrointestinal Neoplasms - pathology | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Proto-Oncogene Proteins c-mdm2 - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - pathology | Skin Neoplasms - pathology | Liposarcoma - drug therapy | Liposarcoma - pathology | Thrombocytopenia - chemically induced | Melanoma - pathology | Spiro Compounds - pharmacokinetics | Neoplasms - drug therapy | Vomiting - chemically induced | Maximum Tolerated Dose | Indoles - adverse effects | Melanoma - drug therapy | Anorexia - chemically induced | Indoles - pharmacokinetics | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasms - pathology | Tumor proteins | Care and treatment | Tumors | Index Medicus
Journal Article
Contemporary Clinical Trials, ISSN 1551-7144, 2016, Volume 51, pp. 56 - 64
Abstract Background There is a considerable body of pre-clinical, epidemiological and randomised data to support the hypothesis that aspirin has the potential... 
Hematology, Oncology and Palliative Medicine | Cardiovascular | Aspirin | Gastro-oesophageal cancer | Breast cancer | Prostate cancer | Colorectal cancer | Randomised controlled trial | ADJUVANT CHEMOTHERAPY | MORTALITY | MEDICINE, RESEARCH & EXPERIMENTAL | ANTIINFLAMMATORY DRUG-USE | FOLLOW-UP | RISK | BREAST-CANCER | COLON-CANCER | COLORECTAL-CANCER | PROSTATE-CANCER | RUN-IN | PHARMACOLOGY & PHARMACY | Humans | Male | Tinnitus - chemically induced | Colorectal Neoplasms - drug therapy | Prostatic Neoplasms - blood | Female | Aspirin - therapeutic use | Chemotherapy, Adjuvant | Neoplasm Recurrence, Local - blood | Prostatic Neoplasms - drug therapy | Drug Hypersensitivity - etiology | Double-Blind Method | India - epidemiology | Survival Rate | Stomach Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Disease-Free Survival | Gastrointestinal Hemorrhage - chemically induced | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Intracranial Hemorrhages - chemically induced | Neoplasm Recurrence, Local - epidemiology | Macular Degeneration - chemically induced | Peptic Ulcer - chemically induced | Esophageal Neoplasms - drug therapy | Longitudinal Studies | United Kingdom - epidemiology | Medical research | Relapse | Analysis | Clinical trials | Medicine, Experimental | Metastasis | Epidemiology | Diseases | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 640 - 653
Summary Background Although trastuzumab plus chemotherapy is the standard of care for first-line treatment of HER2-positive advanced gastric cancer, there is... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | SUPPORTIVE CARE | WEEKLY PACLITAXEL | ONCOLOGY | 2ND-LINE CHEMOTHERAPY | IRINOTECAN | LEVEL | PLUS PACLITAXEL | HER2 | CANCER | DOCETAXEL | Follow-Up Studies | Febrile Neutropenia - chemically induced | Humans | Middle Aged | Male | Stomach Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Taxoids - therapeutic use | Antineoplastic Agents - adverse effects | Pneumonia - chemically induced | Aged, 80 and over | Adult | Female | Stomach Neoplasms - chemistry | Adenocarcinoma - chemistry | Taxoids - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Maytansine - adverse effects | Bridged-Ring Compounds - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Maytansine - analogs & derivatives | Anemia - chemically induced | Survival Rate | Thrombocytopenia - chemically induced | Stomach Neoplasms - drug therapy | Maytansine - therapeutic use | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Esophagogastric Junction | Gastrointestinal Hemorrhage - chemically induced | Retreatment | Intention to Treat Analysis | Bridged-Ring Compounds - adverse effects | Aged | Receptor, ErbB-2 - analysis | Trastuzumab | Adenocarcinoma | Medical research | Chemotherapy | Clinical trials | Medicine, Experimental | Metastasis | Esophageal cancer | Cancer | Analysis
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 05/2011, Volume 93, Issue 5, pp. 1053 - 1061
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2012, Volume 57, Issue 4, pp. 803 - 812
Background & Aims Due to its anatomic connection, the liver is constantly exposed to gut-derived bacterial products or metabolites. Disruption of gut... 
Gastroenterology and Hepatology | Probiotics | Hepatocellular carcinoma | Gut homeostasis | Endotoxin | CHRONIC LIVER-DISEASE | INTESTINAL FLORA | BARRIER FUNCTION | IL-6 PRODUCTION | HUMAN FECES | BACTERIAL TRANSLOCATION | REAL-TIME PCR | GROUP-SPECIFIC PRIMERS | GASTROENTEROLOGY & HEPATOLOGY | PREDOMINANT BACTERIA | Diethylnitrosamine - pharmacology | Diethylnitrosamine - toxicity | Endotoxins - blood | Alkylating Agents - pharmacology | Humans | Liver Neoplasms, Experimental - chemically induced | Male | Gastroenteritis - drug therapy | Lactobacillus - drug effects | HMGB1 Protein - metabolism | Carcinoma, Hepatocellular - etiology | Carcinoma, Hepatocellular - blood | Homeostasis - drug effects | Liver Neoplasms, Experimental - microbiology | Liver Neoplasms, Experimental - pathology | Penicillins - pharmacology | Dextran Sulfate - pharmacology | Endotoxins - metabolism | Liver Cirrhosis - complications | Gastrointestinal Tract - physiopathology | Gastrointestinal Tract - microbiology | Rats | Liver Cirrhosis - blood | Probiotics - pharmacology | Rats, Sprague-Dawley | Disease Progression | Bifidobacterium - drug effects | Animals | Carcinoma, Hepatocellular - pathology | Gastroenteritis - chemically induced | Gastroenteritis - metabolism | Probiotics - therapeutic use | Anti-Bacterial Agents - pharmacology | Enterococcus - drug effects | Cytokines - biosynthesis | Dextran | Liver cancer | International cooperation | Chromosomal proteins | Metabolites | Genes | Homeostasis | Transplantation of organs, tissues, etc | Sulfates
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, p. e0139394
There are multiple neurological complications of cancer and its treatment. This study assessed the utility of the novel non-invasive ophthalmic technique of... 
CAPECITABINE | SURROGATE | OXALIPLATIN | CISPLATIN | MULTIDISCIPLINARY SCIENCES | DAMAGE | Capecitabine - administration & dosage | Hyperalgesia - chemically induced | Pain Threshold - physiology | Humans | Middle Aged | Erythromelalgia - chemically induced | Male | Epirubicin - administration & dosage | Stomach Neoplasms - physiopathology | Cisplatin - administration & dosage | Organoplatinum Compounds - administration & dosage | Nerve Fibers - physiology | Liver Neoplasms - physiopathology | Pain Threshold - drug effects | Female | Liver Neoplasms - secondary | Vibration - adverse effects | Hot Temperature - adverse effects | Nerve Fibers - drug effects | Neural Conduction | Trastuzumab - administration & dosage | Nerve Regeneration | Stomach Neoplasms - drug therapy | Microscopy, Confocal - methods | Cold Temperature - adverse effects | Hyperalgesia - physiopathology | Erythromelalgia - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Esophageal Neoplasms - physiopathology | Cornea - innervation | Aged | Nerve Fibers - ultrastructure | Antineoplastic Agents, Alkylating - adverse effects | Esophageal Neoplasms - drug therapy | Organoplatinum Compounds - adverse effects | Complications and side effects | Cancer patients | Care and treatment | Polyneuropathies | Gastrointestinal cancer | Development and progression | Genetic aspects | Research | Risk factors | Conduction | Cornea | Confocal microscopy | Diabetic neuropathy | Metastasis | Peripheral neuropathy | Cancer therapies | Lymph nodes | Nerve conduction | Pain | Platinum | Education | Conduction heating | Vibration perception | Sensory testing | Pain perception | Vibration | Thresholds | Complications | Invasiveness | Patients | Esophagus | Regeneration | Chemotherapy | Microscopy | Neurological complications | Morphology | Skin | Diabetes | Endocrinology | Cancer
Journal Article
Nature, ISSN 0028-0836, 2013, Volume 499, Issue 7456, pp. 97 - 101
Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several... 
HEPATOCELLULAR-CARCINOMA | HEPATIC STELLATE CELLS | ACID | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | PHENOTYPE | BACTERIUM | MECHANISMS | STRESS | EXPRESSION | CLOSTRIDIUM | Fatty Liver - pathology | Carcinoma, Hepatocellular - prevention & control | Humans | Fatty Liver - complications | Cellular Senescence - drug effects | Hepatic Stellate Cells - metabolism | Liver Neoplasms - complications | Male | Hepatic Stellate Cells - cytology | Interleukin-1beta - deficiency | Liver Neoplasms - etiology | Carcinoma, Hepatocellular - complications | Dietary Fats - pharmacology | Non-alcoholic Fatty Liver Disease | Carcinoma, Hepatocellular - etiology | Disease Models, Animal | Hepatic Stellate Cells - drug effects | DNA Damage - drug effects | Hepatic Stellate Cells - secretion | Liver Neoplasms - prevention & control | Bacteria - metabolism | Dietary Fats - adverse effects | Obesity - chemically induced | Cytokines - metabolism | Deoxycholic Acid - blood | Mice, Inbred C57BL | Risk Factors | Cells, Cultured | Cytokines - secretion | Gastrointestinal Tract - microbiology | Bile Acids and Salts - metabolism | Gastrointestinal Tract - drug effects | Gastrointestinal Tract - metabolism | Obesity - metabolism | Phenotype | Animals | Deoxycholic Acid - metabolism | Liver Neoplasms - metabolism | Anti-Bacterial Agents - pharmacology | Mice | Carcinoma, Hepatocellular - metabolism | Liver cancer | Obesity | Microbial metabolism | Development and progression | Genetic aspects | Research | Health aspects | Proteins | Cell growth | Weight control | Rodents | Index Medicus
Journal Article